Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Dimethyl Fumarate Inhibits the Nuclear Factor kappaB Pathway in Breast Cancer Cells by Covalent Modification of p65.
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.
FDA approves Genzyme’s AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing multiple sclerosis
Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England.
Genentech and Biogen Idec announce top-line results from a Phase II/III clinical trial of Rituxan in primary-progressive multiple sclerosis
Improvements in cognition, quality of life, and physical performance with clinical Pilates in multiple sclerosis: a randomized controlled trial.
Retinyl Palmitate Supplementation Modulates T-bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients.
Masitinib in Patients with Progressive or Relapse-Free Secondary Multiple Sclerosis
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
Headache in relapse and remission phases of multiple sclerosis: A case-control study.
Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection.
LKB1/STRAD promotes axon initiation during neuronal polarization.
Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials.
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study.
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas.
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.
Bioengineered cell culture systems of central nervous system injury and disease.
Episode 3 with Drs. Daren Austin and Susan Van Meter on the MIRROR trial of ofatumumab
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
Extavia Prescribing Information
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: A randomized clinical trial.
Gordon Research Conference on In Vivo Magnetic Resonance

Pages